Close Menu

NEW YORK (GenomeWeb) – Computational biology startup Camp4 Therapeutics has emerged from stealth mode and closed on a $30 million Series A round of venture capital.

Andreessen Horowitz led the round, with participation from Polaris Partners and the Kraft Group. Polaris Partners supported an earlier seed round, according to Cambridge, Massachusetts-based Camp4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.